West Nile virus vaccine (Sanofi Pasteur)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameWest Nile virus vaccine (Sanofi Pasteur)

Drug Alias NameChimeriVax-West NileChimeriVax-WN02ChimeriVax

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis AWest Nile FeverEncephalitis, Japanese

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesThailandPhilippines

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAcambis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi Pasteur

Active IndicationsN/A

Inactive IndicationsHepatitis AWest Nile FeverEncephalitis, Japanese

Other Information

ATC CodeN/A